Treatment of diabetic macular edema is not always followed by visual function recovery. Identification of visual outcome predictors of anti–vascular endothelial growth factor therapy is needed for better diabetic macular edema treatment management. Optical coherence tomography leakage, which maps sites of lower reflectivity within the retina, appears to be a robust biomarker of diabetic macular edema treatment response.